Format

Send to

Choose Destination
Blood Transfus. 2013 Jan;11(1):71-4. doi: 10.2450/2012.0153-11. Epub 2012 Jun 28.

Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan.

Author information

1
Department of Paediatrics, Chung Shan Medical University Hospital, Taichung; School of Medicine, Chung Shan Medical University, Taichung, Taiwan

Abstract

BACKGROUND:

The development of red blood cell (RBC) antibodies can significantly complicate transfusion therapy in transfusion-dependent patients with thalassaemia. However, few data are available on the frequency of RBC alloimmunisation in the Chinese population with β-thalassaemia major.

MATERIALS AND METHODS:

In this retrospective study, we investigated the development of RBC antibodies among Chinese patients with β-thalassaemia major who had received long-term transfusion therapy with leucodepleted blood in our hospital over a period of 20 years.

RESULTS:

Of the 64 patients studied, six (9.4%) developed RBC alloantibodies, including four anti-E, one anti-C and one anti-"Mi(a)". All of the six alloimmunised patients had experienced previous transfusion reactions, while only 12 of the 58 non-immunised patients had had previous transfusion reactions (100% vs 15.5%; p <0.001). After subsequent transfusions with RBC which were negative for the antigens for the corresponding alloantibodies, all the RBC alloantibodies became undetectable within 1 year without additional interventions to eliminate them.

CONCLUSIONS:

RBC alloantibodies in Chinese patients with β-thalassaemia major in Taiwan were different from those in other populations. The development of RBC alloantibodies was associated with previous transfusion reactions. Additional treatment may not be necessary for patients with alloantibodies.

PMID:
22790261
PMCID:
PMC3557491
DOI:
10.2450/2012.0153-11
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Data Conversion Labs Icon for PubMed Central
Loading ...
Support Center